Human serum albumin incorporating synthetic heme: Red blood cell substitute without hypertension by nitric oxide scavenging

Journal of Biomedical Materials Research - Part A

Volumn 64, Issue 2, 2003, Pages 257-261

  Tsuchida, Eishun ^a   Komatsu, Teruyuki ^a   Matsukawa, Yasuko ^a   Nakagawa, Akito ^a   Sakai, Hiromi ^a   Kobayashi, Koichi ^b   Suematsu, Makoto ^b  

^a WASEDA UNIVERSITY   (Japan)

^b KEIO UNIVERSITY   (Japan)

Author keywords

Human serum albumin; Hypertension; Nitric oxide; Red blood cell substitute; Synthetic heme

Indexed keywords

BLOOD; CELLS; DERIVATIVES; HEMOGLOBIN; NITROGEN OXIDES; VISUALIZATION;

BLOOD PRESSURE;

BIOMEDICAL ENGINEERING;

BLOOD SUBSTITUTE; ENDOTHELIAL DERIVED RELAXING FACTOR; HEME DERIVATIVE; HEMOGLOBIN; HEMOPROTEIN; IRON DERIVATIVE; NITRIC OXIDE; RECOMBINANT HUMAN SERUM ALBUMIN; SERUM ALBUMIN; TETRAPHENYPORPHINATOIRON DERIVATIVE; UNCLASSIFIED DRUG; HEME; IRON TETRAPHENYLPORPHYRIN; METALLOPORPHYRIN; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOLE; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DRUG PENETRATION; ERYTHROCYTE; HEART RATE; HYPERTENSION; MALE; NONHUMAN; RAT; VASOCONSTRICTION; VENULE; ANESTHESIA; ANIMAL; BLOOD; BLOOD FLOW; CAPILLARY PERMEABILITY; CHEMICALLY INDUCED DISORDER; CHEMISTRY; CYTOLOGY; DRUG EFFECT; INTESTINE; MICROCIRCULATION; PHYSIOLOGY; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; VASCULARIZATION; WISTAR RAT;

ANESTHESIA; ANIMALS; BLOOD PRESSURE; BLOOD SUBSTITUTES; CAPILLARY PERMEABILITY; ENDOTHELIUM, VASCULAR; ERYTHROCYTES; HEART RATE; HEME; HYPERTENSION; INTESTINES; MALE; METALLOPORPHYRINS; MICROCIRCULATION; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; RATS; RATS, WISTAR; RECOMBINANT PROTEINS; REGIONAL BLOOD FLOW; SERUM ALBUMIN;

EID: 0042924431     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbm.a.10324     Document Type: Article

References (25)

1. Tsuchida E. Perspectives of blood substitutes. In: Tsuchida E, editor. Blood substitutes: Present and future perspectives. Lausanne: Elsevier Science; 1998. p 1-14.
2. Chang TMS. Recent and future developments in modified hemoglobin and microencapsulated hemoglobin as red blood cell substitutes. Artif Cell Blood Sub 1997;25:1-24.
3. Keipert PE, Gonzales A, Gomez CL, MacDonald VW, Hess JR, Winslow RM. Acute changes in systemic blood pressure and urine output of conscious rats following exchange transfusion with diaspirin-crosslinked hemoglobin solution. Transfusion 1993;33:701-708.
4. Hess JR, MacDonald VW, Brinkley VVW. Synthetic and pulmonary hypertension after resuscitation with cell-free hemoglobin. J Appl Physiol 1993;74:1769-1778.
5. Schultz SC, Grady B, Cole F, Hamilton I, Burhop K, Malcolm DS. A role for endothelin and nitric oxide in the pressor response to diaspirin cross-linked hemoglobin. J Lab Clin Med 1993;122:301-308.
6. Rooney MW, Hirsch LJ, Mathru M. Hemodilution with oxyhemoglobin: Mechanism of oxygen delivery and its superaugmentation with a nitric oxide donor (sodium nitroprusside). Anesthesiology 1993;79:60-72.
7. Thompson A, McGarry AE, Valeri CR, Lieberthal W. Stroma-free hemoglobin increases blood pressure and GFR in the hypotensive rat: Role of nitric oxide. J Appl Physiol 1994;77:2348-2354.
8. Sharma AC, Singh G, Gulati A. Role of NO mechanism in cardiovascular effects of diaspirin cross-linked hemoglobin in anesthetized rats. Am J Physiol 1995;269:H1379-H1399.
9. Moisan S, Drapeau G, Burhop KE, Rioux F. Mechanism of the acute pressor effect and bradycardia elicited by disapirin crosslinked hemoglobin in anesthetized rats. Can J Physiol Pharmacol 1998;76:434-442.
10. Malcom DS, Hamilton IN, Schultz SC, Cole F, Burhop KE. Characterization of the hemodynamic response to intravenous disapirin crosslinked hemoglobin solution in rats. Artif Cell Blood Sub 1994;22:91-107.
11. 2-carrying hemoprotein. Bioconjugate Chem 1999; 10:797-802.
12. 2-derivery, and reduction of the oxidized hemin sites by red blood cells. Bioconjugate Chem 2000;11:46-50.
13. Sumi A, Ohtani W, Kobayashi K, Ohmura T, Yokoyama K, Nishida M, Suyama T. Purification and physicochemical properties of recombinant human serum albumin. In: Rivat C, Stoltz J-F, editors. Biotechnology of blood proteins, Vol. 227. Montrouge: John Libbey Eurotext; 1993. p 293-298.
14. Komatsu T, Matsukawa Y, Tsuchida E. Reaction of nitric oxide with synthetic hemoproteins: Human serum albumin incorporating tetraphenylporphinato-iron(II) derivative. Bioconjugate Chem 2001;12:71-75.
15. 2-binding properties of tetraphenylporphyrinato-iron(II) derivatives bearing a proximal imidazole covalently bound at the β-pyrrolic position. J Chem Soc Parkin Trans 2 1995;1995:747-753.
16. Sakai H, Takeoka S, Park SI, Kose T, Hamada K, Izumi Y, Yoshizu A, Nishide H, Tsuchida E. Surface modification of hemoglobin vesicles with poly(ethyleneglycol) and effects on aggregation, viscosity, and blood flow during 90% exchange transfusion in anesthetized rats. Bioconjugate Chem 1997;8:15-22.
17. Guyton AC. Textbook of medical physiology, 7th ed. Philadelphia: Saunders; 1986. p 348-360.
18. Gould SA, Moss GS. Clinical development of human polymerized hemoglobin as a blood substitute. World J Surg 1986;20:1200-1207.
19. Guyton AC, Ross JM, Carrier O, Walker JR. Evidence for tissue oxygen demand as the major factor causing autoregulation. Circ Res 1964;14:1-60.
20. Vandegriff KD, Winslow RM. A theoretical analysis of oxygen transport: A new strategy for the design of hemoglobin-based red cell substitutes. In: Winslow RM, Vandegriff KD, Intaglietta M, editors. Blood substitutes: Physiological basis of efficiency. Boston: Birkhauser; 1995. p 143-154.
21. Tsai AG, Kerger H, Intaglietta M. Microcirculatory consequences of blood substitution with αα-hemoglobin. In: Winslow RM, Vandegriff KD, Intaglietta M, editors. Blood substitutes: Physiological basis of efficiency. Boston: Birkhauser; 1995. p 155-174.
22. Rohlfs RJ, Bruner E, Chiu A, Gonzales ML, Magde D. Arterial blood pressure responses to cell-free hemoglobin solutions and the reaction with nitric oxide. J Biol Chem 1998;273:12128-12134.
23. Malek AM, Izumo S. Control of endotherial cell gene expression by flow. J Biomech 1995;28:1515-1528.
24. Doherty DH, Doyle MP, Curry SR, Vali RT, Fattor TJ, Olson JS, Lemon DD. Rate of reaction with nitric oxide determines the hypertensive effect of cell-free hemoglobin. Nat Biotechnol 1998;16:672-676.
25. Sharma VS, Traylor TG, Gardiner R, Mizukami H. Reaction of nitric oxide with heme proteins and model compounds of hemoglobin. Biochemistry 1987;26:3837-3843.